Liu et al. revealed that EIF3J-DT could promote proliferation and reduce apoptosis in CRC cells, revealing that EIF3J-DT was a risk factor and possessed oncogenic functions in CRC [26]. This evidence concerns the gene EIF3J and colorectal carcinoma.